Effects of oral doxofylline and procaterol on chronic obstructive pulmonary disease: A randomized crossover study - Amsterdam 2025

Revisiting established asthma and COPD therapies: new data and evolving perspectives

Chair(s): Thérèse Lapperre, Andrea Portacci

Session type: Poster session

Effects of oral doxofylline and procaterol on chronic obstructive pulmonary disease: A randomized crossover study

Sarawut Panichaporn

EVENTS HOME

Abstract

Previous presentation

Next presentation

Session content

Prophylactic azithromycin in preventing recurrent acute exacerbations of COPD and blood eosinophil counts: a hospital review

Mathieu Saint-pierre

Poster

Abstract

Changes in sensory and affective components of dyspnea in severe COPD treated with endobronchial valves (EBV)

Nathalie Bautin

Poster

Abstract

Persistence and outcomes after 12 months of patients with COPD initiating formoterol/glycopyrronium/budesonide in Spain. ORESTES study

Bernardino Alcazar Navarrete

Poster

Abstract

Repeated sampling improves identification of eosinophilic COPD patients

Sophie Shields

Poster

Abstract

Serum levels of salbutamol in healthy volunteers and patients with chronic obstructive pulmonary disease.

Kristian Brat

Poster

Abstract

Chinese patients receiving ICS/LABA or LAMA-containing asthma therapy characterisation: Retrospective cohort study

Zhiliu Tang

Poster

Abstract

Detection of Collateral Ventilation in Pre-Planning for Bronchoscopic Lung Volume Reduction Procedures Using Advanced CT Imaging

Nina Eikelis

Poster

Abstract

Reduction of Hyperinflation and Airway obstruction through BiPAP Ventilation using Expiratory-Flow-Technology (EFL)

Markus Henke

Abstract

Home high-flow therapy: insights from remote-monitoring and linked routine clinical data

Lorna Hickey

Abstract

High variability of blood eosinophil (bEOS) levels among patients with chronic obstructive pulmonary disease (COPD) in the real world

Tracy Burgess

Poster

Abstract

Effects of oral doxofylline and procaterol on chronic obstructive pulmonary disease: A randomized crossover study

Sarawut Panichaporn

Abstract

Effectiveness Salmeterol-Fluticasone and Indacaterol on FEV1/FVC Post-Tuberculosis Patient at dr. H. Abdul Moeloek Hospital Lampung Province Indonesia

Retno Ariza Soemarwoto

Poster

Abstract

What is the effective pharmacotherapy for post TB COPD? An observational multicentric, real world effectiveness study from India

Sujata Chauthmal

Poster

Abstract

Real-world evidence (RWE) study on clinical outcomes in asthma: fluticasone furoate/vilanterol (FF/VI) versus (vs) budesonide/formoterol (BUD/FOR)

Ashley Woodcock

Poster

Abstract

Effect of Long-Term Oxygen Therapy on Survival in COPD Patients with Moderate Resting Hypoxia after Acute Exacerbation: A Propensity Score-Weighted Analysis

Kenta Nishiyama

Poster

Abstract

Risk of future exacerbations in patients with severe uncontrolled asthma in primary care

Caroline Stridsman

Poster

Abstract

General physicians experience and perception of symptoms control in patients of asthma changed to branded generic formulation of Salmeterol/Fluticasone in Spain: The ORIGEN study

Jorge Rábago Castro

Poster

Abstract

Inflammation, lung function, symptoms and reliever use in chronic obstructive pulmonary disease

Mona Bafadhel

Poster

Abstract

High- vs. low-intensity inspiratory muscle training in asthma: effects on exercise capacity and clinical characteristics

Cahidenur Kocak

Poster

Abstract

Phase III/IV trials of COPD maintenance management assess heterogeneous outcomes

Vi Truong

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}